Alexandra Garcilazo-Reyes, MD

home / authors / alexandra-garcilazo-reyes,-md

Articles

Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma

Nora Sobrevilla-Moreno, MD;Daniel Rivera-Sánchez, MD;Dorian Y. García-Ortega, MD;Diego López-Macías, MD;Alexandra Garcilazo-Reyes, MD;Miguel A. Álvarez-Avitia, MD

September 16th 2021

This clinical quandary discusses oligoprogressive disease in metastatic melanoma and how treatment with immunotherapy and targeted therapy affect the disease.

Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?

Nora Sobrevilla-Moreno, MD;Javier I. Altamirano-Garcia, MD;Martin Granados-Garcia, MD;Alexandra Garcilazo-Reyes, MD;Marytere Herrera-Martinez, MD;Miguel A. Alvarez-Avitia, MD

June 16th 2020

A 57-year-old man with a heavy smoking and alcohol consumption history, but no comorbidities, presented with pharyngeal pain to his primary care physician’s office. He received empirical treatment with oral antibiotics and experienced partial improvement. A couple of months later, he developed a left cervical mass with progressive growth. A head and neck CT scan revealed a hypopharyngeal tumor. Results of a tumor biopsy indicated an ulcerated, moderately differentiated squamous cell carcinoma (SCC) with lymphovascular invasion. The patient was sent to our institution for treatment.